Furthermore, ALS patients also displayed decreased SOD1, FUS, and VEGF methylation on promoter regions [175], synergistically with hypermethylation of promoters of human glutamate transporter EAAT2, which has been suggested as an ALS contributor [176]. The gene discussed is SLC1A2; the disease is amyotrophic lateral sclerosis.